Sulfation of 25-hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation

• Published in: American journal of physiology: endocrinology and metabolism Vol. 306; no. 2; pp. E123 - E130
• Main Authors: Ren, Shunlin, Ning, Yanxia
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 15.01.2014
• Subjects: Animals; Apoptosis; Atherosclerosis; Biosynthesis; Cell Proliferation; Cholesterol Esters - metabolism; Humans; Hydroxycholesterols - metabolism; Inflammation - metabolism; Lipid Metabolism; Lipids; Liver diseases; Liver X Receptors; Metabolic disorders; Orphan Nuclear Receptors - physiology; Protein expression; Review; Sterol Regulatory Element Binding Proteins - physiology; Sulfatases - metabolism; nuclear receptor; 25HC3S, LXR, SREBPs, IκB, NF-κB, PPARs; cholesterol and triglyceride metabolism; oxysterol sulfate
• ISSN: 0193-1849; 1522-1555
• DOI: 10.1152/ajpendo.00552.2013

Intracellular lipid accumulation, inflammatory responses, and subsequent apoptosis are the major pathogenic events of metabolic disorders, including atherosclerosis and nonalcoholic fatty liver diseases. Recently, a novel regulatory oxysterol, 5-cholesten-3b, 25-diol 3-sulfate (25HC3S), has been identified, and hydroxysterol sulfotransferase 2B1b (SULT2B1b) has been elucidated as the key enzyme for its biosynthesis from 25-hydroxycholesterol (25HC) via oxysterol sulfation. The product 25HC3S and the substrate 25HC have been shown to coordinately regulate lipid metabolism, inflammatory responses, and cell proliferation in vitro and in vivo. 25HC3S decreases levels of the nuclear liver oxysterol receptor (LXR) and sterol regulatory element-binding proteins (SREBPs), inhibits SREBP processing, subsequently downregulates key enzymes in lipid biosynthesis, decreases intracellular lipid levels in hepatocytes and THP-1-derived macrophages, prevents apoptosis, and promotes cell proliferation in liver tissues. Furthermore, 25HC3S increases nuclear PPARγ and cytosolic IκBα and decreases nuclear NF-κB levels and proinflammatory cytokine expression and secretion when cells are challenged with LPS and TNFα. In contrast to 25HC3S, 25HC, a known LXR ligand, increases nuclear LXR and decreases nuclear PPARs and cytosol IκBα levels. In this review, we summarize our recent findings, including the discovery of the regulatory oxysterol sulfate, its biosynthetic pathway, and its functional mechanism. We also propose that oxysterol sulfation functions as a regulatory signaling pathway.